UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
February 12, 2019
Accession Number:
0001654954-18-014360
Submission Type:
POS AM
CIK:
0001681682
Company Name:
ENDRA Life Sciences Inc.
File Number:
333-214724